The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
3-year safety follow-up of radium-223 dichloride (Ra-223) in patients (Pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (Mets) from ALSYMPCA.
 
Chris Parker
Honoraria - Astellas Pharma; Takeda
Consulting or Advisory Role - Bayer; BN ImmunoTherapeutics; Janssen
Research Funding - Bayer (Inst)
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Abbvie; Bavarian Nordic; Dava Oncology; Endocyte; Mannkind; UpToDate
Consulting or Advisory Role - Amgen; AVEO; BIND Biosciences; Janssen Biotech
Speakers' Bureau - Bayer; Caris MPI; Dendreon; GlaxoSmithKline; Medivation; Millennium; Sanofi
Research Funding - Endocyte (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Parexel (Inst); Progenics (Inst); US Oncology (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer/Onyx; Celgene; Dendreon; Exelixis; Genentech/Roche; Novartis; Pfizer; US Oncology
 
A. Oliver Sartor
Consulting or Advisory Role - Bayer; Bayer
Research Funding - Bayer; Bayer
 
Robert E. Coleman
Expert Testimony - Novartis
 
Fang Fang
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Irene Skjorestad
Employment - Bayer
Stock and Other Ownership Interests - Algeta ASA
 
Sten Nilsson
Consulting or Advisory Role - Bayer (Inst)